PDCD1 and melanoma: We also analyzed the results of two clinical trials of anti-PD1 treatment in melanoma and found that SQLE expression was inversely associated with cytotoxic lymphocyte levels (CTLs), OS, and PFS in melanoma patients (Figure 8B, p < 0.05).